§ 866.2420. Oxidase screening test for gonorrhea.
181 words·~1 min read·
/us/cfr/t21/s§ 866.2420·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Identification. An oxidase screening test for gonorrhea is an in vitro device that consists of the articles intended to identify by chemical reaction, cytochrome oxidase, an oxidizing enzyme that is associated with certain bacteria including Neisseria gonorrhoeae. A sample of a male's urethral discharge is obtained on a swab which is placed into a wetting agent containing an ingredient that will react with cytochrome oxidase. When cytochrome oxidase is present, the swab turns a dark purple color within 3 minutes. Because it is unlikely that cytochrome oxidase-positive organisms other than Neisseria gonorrhoeae are present in the urethral discharge of males, the identification of cytochrome oxidase with this device indicates presumptive infection of the patient with the causative agent of gonorrhea.
(b)Classification. Class III (premarket approval) (transitional device).
(c)Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before this device may be commercially distributed. See § 866.3. [47 FR 50823, Nov. 9, 1982, as amended at 52 FR 17734, May 11, 1987]